• BFH772 (VEGFR2 inhibitor): Workflow Guide

  2026-08-15

  BFH772 is a selective small-molecule VEGFR2 inhibitor for controlled studies of VEGFR2-mediated signaling and angiogenesis. It is suited to biochemical, cellular, and tumor-model research workflows that can accommodate organic solvents, but not to water-based formulations or experiments requiring broad-spectrum kinase inhibition.

• Baicalin Restores Adult Visual Plasticity in Amblyopia

  2026-08-14

  A 2026 NeuroImage study reports that baicalin reactivates ocular dominance plasticity and restores visual acuity in adult amblyopic mice, overcoming a major limitation of age-dependent cortical plasticity. The results connect recovery to reduced GABAergic inhibition and perineuronal-net expression in V1, while identifying a dose-dependent experimental framework for further preclinical investigation.

• Doxycycline Hyclate: From MMP Target to BBB Assay

  2026-08-14

  Doxycycline hyclate is more than a broad-spectrum antibiotic: it is a useful matrix metalloproteinases inhibitor for connecting MMP activity with blood-brain barrier failure and neuronal injury. This article translates arsenic-neurotoxicity findings into practical assay decisions while defining the limits of antiviral and antimalarial extrapolation.

• ABT-263 Workflows for Apoptosis Research

  2026-08-13

  ABT-263 (Navitoclax) gives cancer researchers a broad Bcl-2-family perturbation tool for apoptosis assays, resistance studies, and leukemia models. This practical guide connects compound handling with mitochondrial priming, caspase readouts, and the non-cell-autonomous FGF resistance mechanism described in the reference study.

• Marein Reverses ABCG2-Mediated Chemoresistance

  2026-08-13

  The reference study identifies marein, a flavonoid glycoside from Coreopsis tinctoria Nutt, as a competitive inhibitor of the ABCG2 drug transporter. By increasing intracellular exposure to ABCG2 substrate drugs and restoring drug sensitivity in resistant cancer cells, the work provides a mechanistic framework for studying transporter-mediated chemotherapy failure.

• Sulfamonomethoxine Workflows for Applied Research

  2026-08-12

  Sulfamonomethoxine supports mechanistic antimicrobial assays, veterinary and aquaculture research, and controlled environmental fate studies. This guide connects DHPS inhibition with practical stock preparation, degradation kinetics, aquatic toxicity testing, and troubleshooting of solvent, recovery, and plasma-treatment effects.

• CML NETs and Tyrosine Kinase Inhibitors

  2026-08-12

  The reference study shows that neutrophil extracellular trap formation is increased in chronic myeloid leukemia and can be further modified by tyrosine kinase inhibitors, particularly ponatinib. By combining patient-derived neutrophils with a BCR-ABL1-expressing HoxB8 model and pharmacologic pathway inhibition, the work implicates PAD4-dependent NET biology as a possible contributor to treatment-associated vascular risk.

• Recombinant Mouse Sonic Hedgehog Assay Guide

  2026-08-11

  Build reproducible SHH dose-response, alkaline phosphatase, and ex vivo genital-tubercle assays with a defined recombinant ligand. This guide translates comparative developmental findings into practical workflows for limb and brain patterning studies and congenital malformation research.

• Sulfo-Cy5 NHS Ester: Aqueous Labeling Workflows

  2026-08-10

  Sulfo-Cy5 NHS ester enables bright, amine-selective labeling of proteins and other biomolecules without relying on organic co-solvents. This guide translates its water-compatible chemistry into reproducible conjugation, cellular imaging, uptake, and troubleshooting workflows, including assay ideas inspired by recent nanostructure immunotherapy research.

• WZ4003: Practical NUAK1/2 Inhibitor Workflows

  2026-08-09

  WZ4003 links selective NUAK1/2 inhibition to measurable changes in MYPT1 phosphorylation, cell-cycle progression, migration, invasion, and pathological tau. This workflow-focused guide helps researchers distinguish target engagement from nonspecific toxicity across cancer and brain-slice models.

• Ethanamizuril and Sulfachloropyridazine in Coccidiosis

  2026-08-08

  The reference study combines 16S rRNA gene sequencing with LC-MS/MS metabolomics to examine how ethanamizuril, Sulfachloropyridazine, and their combination affect chickens infected with Eimeria tenella. Its main contribution is a systems-level view showing that anticoccidial efficacy and antibacterial treatment can be associated with distinct changes in cecal microbial communities and metabolites.

• Mitoxantrone and ABCG2: A Translational Playbook

  2026-08-07

  Mitoxantrone is more than a topoisomerase II inhibitor: its translational performance depends on intracellular exposure, apoptosis competence, and ABCG2-mediated efflux. This thought-leadership article translates recent marein findings into a practical framework for studying resistance, combination strategies, B-CLL models, and the emerging anti-orthopoxvirus research opportunity.

• Genetic Streamlining of 400-Isovalerylspiramycin I Productio

  2026-08-07

  The referenced study demonstrates the targeted in-frame deletion of the 3-O-acyltransferase gene in Streptomyces spiramyceticus, yielding a strain that produces predominantly 400-isovalerylspiramycin I. This advance reduces antibiotic component complexity, facilitating more reproducible macrolide research and improved quality control.

• Doxycycline Hyclate: Matrix Metalloproteinases Inhibitor in

  2026-08-06

  Doxycycline hyclate offers targeted inhibition of MMP-2 and MMP-9, unlocking robust protection of blood-brain barrier integrity in arsenic-induced neurotoxicity models. Its versatile solubility and validated in vivo dosing streamline experimental workflows for translational research.

• Cyclo (-RGDfC) in Integrin-Mediated Cell Adhesion Assays

  2026-08-06

  Cyclo (-RGDfC) empowers researchers with unmatched specificity for αvβ3 integrin targeting in cancer and angiogenesis research. Its robust DMSO solubility, cyclic stability, and proven performance streamline high-throughput workflows and reproducible functional studies.

453 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page